Rajiv De Silva has been appointed chief operating officer of Specialty Pharmaceuticals, Valeant Pharmaceuticals International, effective January 5, 2009. Mr. De Silva will be responsible for overseeing the U.S., Canadian and Australian specialty pharmaceuticals operations. “We are very pleased to have Rajiv join the Valeant team,” said J. Michael Pearson, chairman and chief executive officer of Valeant. “His experience in the global pharmaceutical industry and his track reco...